ReP USP - Resultado da busca

Artigo de periodico
Folate pathway inhibitors, an underestimated and underexplored molecular target for new anti-tuberculosis agents (2023)
Vassiliades, Sandra Valeria ; Borges, Lara Gimenez; Giarolla, Jeanine ; Parise Filho, Roberto
Source: Mini-Reviews in Medicinal Chemistry. Unidade: FCF
Subjects: HOMEOSTASE, TUBERCULOSE, ÁCIDO FÓLICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VASSILIADES, Sandra Valeria et al. Folate pathway inhibitors, an underestimated and underexplored molecular target for new anti-tuberculosis agents. Mini-Reviews in Medicinal Chemistry, v. 23, n. 17, p. 1711-1732, 2023Tradução . . Disponível em: https://doi.org/10.2174/1389557523666230206163154. Acesso em: 14 nov. 2024.
APA
Vassiliades, S. V., Borges, L. G., Giarolla, J., & Parise Filho, R. (2023). Folate pathway inhibitors, an underestimated and underexplored molecular target for new anti-tuberculosis agents. Mini-Reviews in Medicinal Chemistry, 23( 17), 1711-1732. doi:10.2174/1389557523666230206163154
NLM
Vassiliades SV, Borges LG, Giarolla J, Parise Filho R. Folate pathway inhibitors, an underestimated and underexplored molecular target for new anti-tuberculosis agents [Internet]. Mini-Reviews in Medicinal Chemistry. 2023 ; 23( 17): 1711-1732.[citado 2024 nov. 14 ] Available from: https://doi.org/10.2174/1389557523666230206163154
Vancouver
Vassiliades SV, Borges LG, Giarolla J, Parise Filho R. Folate pathway inhibitors, an underestimated and underexplored molecular target for new anti-tuberculosis agents [Internet]. Mini-Reviews in Medicinal Chemistry. 2023 ; 23( 17): 1711-1732.[citado 2024 nov. 14 ] Available from: https://doi.org/10.2174/1389557523666230206163154
Artigo de periodico
Exploring the dark side of tertiary and quaternary structure dynamics in MtbFBPaseII (2023)
Greco, Gabriel Luis Cardoso; Segretti, Natanael; Zapatero, Celerino Abad ; Movahedzadehc, Farahnaz; Hirata, Mario Hiroyuki ; Ferreira, Elizabeth Igne ; Ferreira, Glaucio Monteiro
Source: Journal of Biomolecular Structure and Dynamics. Unidade: FCF
Subjects: TUBERCULOSE, MEDICAMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GRECO, Gabriel Luis Cardoso et al. Exploring the dark side of tertiary and quaternary structure dynamics in MtbFBPaseII. Journal of Biomolecular Structure and Dynamics, 2023Tradução . . Disponível em: https://dx.doi.org/10.1080/07391102.2023.2270528. Acesso em: 14 nov. 2024.
APA
Greco, G. L. C., Segretti, N., Zapatero, C. A., Movahedzadehc, F., Hirata, M. H., Ferreira, E. I., & Ferreira, G. M. (2023). Exploring the dark side of tertiary and quaternary structure dynamics in MtbFBPaseII. Journal of Biomolecular Structure and Dynamics. doi:10.1080/07391102.2023.2270528
NLM
Greco GLC, Segretti N, Zapatero CA, Movahedzadehc F, Hirata MH, Ferreira EI, Ferreira GM. Exploring the dark side of tertiary and quaternary structure dynamics in MtbFBPaseII [Internet]. Journal of Biomolecular Structure and Dynamics. 2023 ;[citado 2024 nov. 14 ] Available from: https://dx.doi.org/10.1080/07391102.2023.2270528
Vancouver
Greco GLC, Segretti N, Zapatero CA, Movahedzadehc F, Hirata MH, Ferreira EI, Ferreira GM. Exploring the dark side of tertiary and quaternary structure dynamics in MtbFBPaseII [Internet]. Journal of Biomolecular Structure and Dynamics. 2023 ;[citado 2024 nov. 14 ] Available from: https://dx.doi.org/10.1080/07391102.2023.2270528
Artigo de periodico
Mycobacterium tuberculosis dihydrofolate reductase inhibitors: State of Art Past 20 Years (2023)
Vassiliades, Sandra Valeria ; Navarausckas, Vitor Bastos; Dias, Marcio Vinicius Bertacine ; Parise Filho, Roberto
Source: Biointerface Research in Applied Chemistry. Unidades: ICB, FCF
Subjects: TUBERCULOSE, FÁRMACOS, MYCOBACTERIUM TUBERCULOSIS, MICROBIOLOGIA, ANTIBIÓTICOS, INIBIDORES DE ENZIMAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VASSILIADES, Sandra Valeria et al. Mycobacterium tuberculosis dihydrofolate reductase inhibitors: State of Art Past 20 Years. Biointerface Research in Applied Chemistry, v. 13, n. 1 p. 1-20 art. 79, 2023Tradução . . Disponível em: https://doi.org/10.33263/BRIAC131.079. Acesso em: 14 nov. 2024.
APA
Vassiliades, S. V., Navarausckas, V. B., Dias, M. V. B., & Parise Filho, R. (2023). Mycobacterium tuberculosis dihydrofolate reductase inhibitors: State of Art Past 20 Years. Biointerface Research in Applied Chemistry, 13( 1 p. 1-20 art. 79). doi:10.33263/BRIAC131.079
NLM
Vassiliades SV, Navarausckas VB, Dias MVB, Parise Filho R. Mycobacterium tuberculosis dihydrofolate reductase inhibitors: State of Art Past 20 Years [Internet]. Biointerface Research in Applied Chemistry. 2023 ; 13( 1 p. 1-20 art. 79):[citado 2024 nov. 14 ] Available from: https://doi.org/10.33263/BRIAC131.079
Vancouver
Vassiliades SV, Navarausckas VB, Dias MVB, Parise Filho R. Mycobacterium tuberculosis dihydrofolate reductase inhibitors: State of Art Past 20 Years [Internet]. Biointerface Research in Applied Chemistry. 2023 ; 13( 1 p. 1-20 art. 79):[citado 2024 nov. 14 ] Available from: https://doi.org/10.33263/BRIAC131.079
Artigo de periodico
Succinylated isoniazid potential prodrug: design of Experiments (DoE) for synthesis optimization and computational study of the reaction mechanism by DFT calculations (2022)
Prieto, Diego Campos ; Araujo, Renan Vinicius de ; Lima, Sara de Souza; Assad, Felipe Zauith; Grayson, Scott M; Braga, Ataualpa Albert Carmo ; Lourenço, Felipe Rebello ; Giarolla, Jeanine
Source: Journal of Molecular Structure. Unidades: IQ, FCF
Subjects: TUBERCULOSE, FÁRMACOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PRIETO, Diego Campos et al. Succinylated isoniazid potential prodrug: design of Experiments (DoE) for synthesis optimization and computational study of the reaction mechanism by DFT calculations. Journal of Molecular Structure, v. 1254, p. 1-7 art. 132323, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.molstruc.2021.132323. Acesso em: 14 nov. 2024.
APA
Prieto, D. C., Araujo, R. V. de, Lima, S. de S., Assad, F. Z., Grayson, S. M., Braga, A. A. C., et al. (2022). Succinylated isoniazid potential prodrug: design of Experiments (DoE) for synthesis optimization and computational study of the reaction mechanism by DFT calculations. Journal of Molecular Structure, 1254, 1-7 art. 132323. doi:10.1016/j.molstruc.2021.132323
NLM
Prieto DC, Araujo RV de, Lima S de S, Assad FZ, Grayson SM, Braga AAC, Lourenço FR, Giarolla J. Succinylated isoniazid potential prodrug: design of Experiments (DoE) for synthesis optimization and computational study of the reaction mechanism by DFT calculations [Internet]. Journal of Molecular Structure. 2022 ; 1254 1-7 art. 132323.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1016/j.molstruc.2021.132323
Vancouver
Prieto DC, Araujo RV de, Lima S de S, Assad FZ, Grayson SM, Braga AAC, Lourenço FR, Giarolla J. Succinylated isoniazid potential prodrug: design of Experiments (DoE) for synthesis optimization and computational study of the reaction mechanism by DFT calculations [Internet]. Journal of Molecular Structure. 2022 ; 1254 1-7 art. 132323.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1016/j.molstruc.2021.132323
Artigo de periodico
Analytical quality by design as an important tool to determine the best analytical conditions for isoniazid and its respective succinylated prodrug (2021)
Rampini, Denise ; Araujo, Renan Vinicius de ; Foitinho, Rodrigo Esteves; Lourenço, Felipe Rebello ; Giarolla, Jeanine
Source: Journal of AOAC International. Unidade: FCF
Subjects: TUBERCULOSE, ANTIBIÓTICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RAMPINI, Denise et al. Analytical quality by design as an important tool to determine the best analytical conditions for isoniazid and its respective succinylated prodrug. Journal of AOAC International, v. 104, n. 1, p. 239–247, 2021Tradução . . Disponível em: https://doi.org/10.1093/jaoacint/qsaa087/5866698. Acesso em: 14 nov. 2024.
APA
Rampini, D., Araujo, R. V. de, Foitinho, R. E., Lourenço, F. R., & Giarolla, J. (2021). Analytical quality by design as an important tool to determine the best analytical conditions for isoniazid and its respective succinylated prodrug. Journal of AOAC International, 104( 1), 239–247. doi:10.1093/jaoacint/qsaa087/5866698
NLM
Rampini D, Araujo RV de, Foitinho RE, Lourenço FR, Giarolla J. Analytical quality by design as an important tool to determine the best analytical conditions for isoniazid and its respective succinylated prodrug [Internet]. Journal of AOAC International. 2021 ; 104( 1): 239–247.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1093/jaoacint/qsaa087/5866698
Vancouver
Rampini D, Araujo RV de, Foitinho RE, Lourenço FR, Giarolla J. Analytical quality by design as an important tool to determine the best analytical conditions for isoniazid and its respective succinylated prodrug [Internet]. Journal of AOAC International. 2021 ; 104( 1): 239–247.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1093/jaoacint/qsaa087/5866698
Artigo de periodico
Design of novel phosphopantetheine adenylyltransferase inhibitors: a potential new approach to tackle Mycobacterium tuberculosis (2021)
Primi, Marina Candido ; Tavares, Maurício Temotheo ; Klein, Larry L; Izard, Tina; Sant'Anna, Carlos M. R; Franzblau, Scott Gary; Ferreira, Elizabeth Igne
Source: Current Topics in Medicinal Chemistry. Unidade: FCF
Subjects: TUBERCULOSE, ANTIBIÓTICOS, INIBIDORES DE ENZIMAS, QUIMIOTERAPIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PRIMI, Marina Candido et al. Design of novel phosphopantetheine adenylyltransferase inhibitors: a potential new approach to tackle Mycobacterium tuberculosis. Current Topics in Medicinal Chemistry, v. 21, p. 1186-1197, 2021Tradução . . Disponível em: https://doi.org/10.2174/1568026621666210728094804. Acesso em: 14 nov. 2024.
APA
Primi, M. C., Tavares, M. T., Klein, L. L., Izard, T., Sant'Anna, C. M. R., Franzblau, S. G., & Ferreira, E. I. (2021). Design of novel phosphopantetheine adenylyltransferase inhibitors: a potential new approach to tackle Mycobacterium tuberculosis. Current Topics in Medicinal Chemistry, 21, 1186-1197. doi:10.2174/1568026621666210728094804
NLM
Primi MC, Tavares MT, Klein LL, Izard T, Sant'Anna CMR, Franzblau SG, Ferreira EI. Design of novel phosphopantetheine adenylyltransferase inhibitors: a potential new approach to tackle Mycobacterium tuberculosis [Internet]. Current Topics in Medicinal Chemistry. 2021 ; 21 1186-1197.[citado 2024 nov. 14 ] Available from: https://doi.org/10.2174/1568026621666210728094804
Vancouver
Primi MC, Tavares MT, Klein LL, Izard T, Sant'Anna CMR, Franzblau SG, Ferreira EI. Design of novel phosphopantetheine adenylyltransferase inhibitors: a potential new approach to tackle Mycobacterium tuberculosis [Internet]. Current Topics in Medicinal Chemistry. 2021 ; 21 1186-1197.[citado 2024 nov. 14 ] Available from: https://doi.org/10.2174/1568026621666210728094804
Artigo de periodico
Malaria and tuberculosis as diseases of neglected populations: state of the art in chemotherapy and advances in the search for new drugs (2020)
Araujo, Renan Vinicius de ; Santos, Soraya da Silva; Sanches, Luccas Missfeldt; Giarolla, Jeanine ; El Seoud, Omar A ; Ferreira, Elizabeth Igne
Source: Memórias do Instituto Oswaldo Cruz. Unidades: IQ, FCF
Subjects: MALÁRIA, TUBERCULOSE, DOENÇAS NEGLIGENCIADAS, FÁRMACOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ARAUJO, Renan Vinicius de et al. Malaria and tuberculosis as diseases of neglected populations: state of the art in chemotherapy and advances in the search for new drugs. Memórias do Instituto Oswaldo Cruz, v. 115, p. 1-20 art. e200229, 2020Tradução . . Disponível em: https://doi.org/10.1590/0074-02760200229. Acesso em: 14 nov. 2024.
APA
Araujo, R. V. de, Santos, S. da S., Sanches, L. M., Giarolla, J., El Seoud, O. A., & Ferreira, E. I. (2020). Malaria and tuberculosis as diseases of neglected populations: state of the art in chemotherapy and advances in the search for new drugs. Memórias do Instituto Oswaldo Cruz, 115, 1-20 art. e200229. doi:10.1590/0074-02760200229
NLM
Araujo RV de, Santos S da S, Sanches LM, Giarolla J, El Seoud OA, Ferreira EI. Malaria and tuberculosis as diseases of neglected populations: state of the art in chemotherapy and advances in the search for new drugs [Internet]. Memórias do Instituto Oswaldo Cruz. 2020 ; 115 1-20 art. e200229.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1590/0074-02760200229
Vancouver
Araujo RV de, Santos S da S, Sanches LM, Giarolla J, El Seoud OA, Ferreira EI. Malaria and tuberculosis as diseases of neglected populations: state of the art in chemotherapy and advances in the search for new drugs [Internet]. Memórias do Instituto Oswaldo Cruz. 2020 ; 115 1-20 art. e200229.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1590/0074-02760200229
Trabalho de evento-resumo
Estudos in silico de pró-fármacos dendriméricos com ação potencial em malária e tuberculose (2020)
Sueyoshi, Sophia Mikiko Oliveira; Silva, João Vitor da ; Prieto, Diego Campos ; Giarolla, Jeanine
Source: Resumos. Conference titles: Simpósio Internacional de Iniciação Científica e Tecnológica da Universidade de São Paulo - SIICUSP. Unidade: FCF
Subjects: MALÁRIA, TUBERCULOSE, FÁRMACOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SUEYOSHI, Sophia Mikiko Oliveira et al. Estudos in silico de pró-fármacos dendriméricos com ação potencial em malária e tuberculose. 2020, Anais.. São Paulo: Universidade de São Paulo - USP, 2020. Disponível em: https://uspdigital.usp.br/siicusp/siicPublicacao.jsp?codmnu=7210. Acesso em: 14 nov. 2024.
APA
Sueyoshi, S. M. O., Silva, J. V. da, Prieto, D. C., & Giarolla, J. (2020). Estudos in silico de pró-fármacos dendriméricos com ação potencial em malária e tuberculose. In Resumos. São Paulo: Universidade de São Paulo - USP. Recuperado de https://uspdigital.usp.br/siicusp/siicPublicacao.jsp?codmnu=7210
NLM
Sueyoshi SMO, Silva JV da, Prieto DC, Giarolla J. Estudos in silico de pró-fármacos dendriméricos com ação potencial em malária e tuberculose [Internet]. Resumos. 2020 ;[citado 2024 nov. 14 ] Available from: https://uspdigital.usp.br/siicusp/siicPublicacao.jsp?codmnu=7210
Vancouver
Sueyoshi SMO, Silva JV da, Prieto DC, Giarolla J. Estudos in silico de pró-fármacos dendriméricos com ação potencial em malária e tuberculose [Internet]. Resumos. 2020 ;[citado 2024 nov. 14 ] Available from: https://uspdigital.usp.br/siicusp/siicPublicacao.jsp?codmnu=7210
Artigo de periodico
Cationic rifampicin nanoemulsion for the treatment of ocular tuberculosis (2020)
Henostroza, Mirla Anali Bazán; Melo, Katherine Jasmine Curo; Yukuyama, Megumi Nishitani ; Löbenberg, Raimar ; Bou-Chacra, Nadia Araci
Source: Colloids and Surfaces A: Physicochemical and Engineering Aspects. Unidade: FCF
Subjects: TUBERCULOSE, QUITOSANA, NANOTECNOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HENOSTROZA, Mirla Anali Bazán et al. Cationic rifampicin nanoemulsion for the treatment of ocular tuberculosis. Colloids and Surfaces A: Physicochemical and Engineering Aspects, v. 597, p. 1-11 art. 124755, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.colsurfa.2020.124755. Acesso em: 14 nov. 2024.
APA
Henostroza, M. A. B., Melo, K. J. C., Yukuyama, M. N., Löbenberg, R., & Bou-Chacra, N. A. (2020). Cationic rifampicin nanoemulsion for the treatment of ocular tuberculosis. Colloids and Surfaces A: Physicochemical and Engineering Aspects, 597, 1-11 art. 124755. doi:10.1016/j.colsurfa.2020.124755
NLM
Henostroza MAB, Melo KJC, Yukuyama MN, Löbenberg R, Bou-Chacra NA. Cationic rifampicin nanoemulsion for the treatment of ocular tuberculosis [Internet]. Colloids and Surfaces A: Physicochemical and Engineering Aspects. 2020 ; 597 1-11 art. 124755.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1016/j.colsurfa.2020.124755
Vancouver
Henostroza MAB, Melo KJC, Yukuyama MN, Löbenberg R, Bou-Chacra NA. Cationic rifampicin nanoemulsion for the treatment of ocular tuberculosis [Internet]. Colloids and Surfaces A: Physicochemical and Engineering Aspects. 2020 ; 597 1-11 art. 124755.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1016/j.colsurfa.2020.124755
Artigo de periodico
Rifampicin nanocrystals: towards an innovative approach to treat tuberculosis (2020)
Melo, Katherine Jasmine Curo; Henostroza, Mirla Anali Bazan; Löbenberg, Raimar ; Bou-Chacra, Nadia Araci
Source: Materials Science and Engineering: C. Unidade: FCF
Subjects: TUBERCULOSE, ANTIBIÓTICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MELO, Katherine Jasmine Curo et al. Rifampicin nanocrystals: towards an innovative approach to treat tuberculosis. Materials Science and Engineering: C, v. 112, p. 1-13 art. 110895, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.msec.2020.110895. Acesso em: 14 nov. 2024.
APA
Melo, K. J. C., Henostroza, M. A. B., Löbenberg, R., & Bou-Chacra, N. A. (2020). Rifampicin nanocrystals: towards an innovative approach to treat tuberculosis. Materials Science and Engineering: C, 112, 1-13 art. 110895. doi:10.1016/j.msec.2020.110895
NLM
Melo KJC, Henostroza MAB, Löbenberg R, Bou-Chacra NA. Rifampicin nanocrystals: towards an innovative approach to treat tuberculosis [Internet]. Materials Science and Engineering: C. 2020 ; 112 1-13 art. 110895.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1016/j.msec.2020.110895
Vancouver
Melo KJC, Henostroza MAB, Löbenberg R, Bou-Chacra NA. Rifampicin nanocrystals: towards an innovative approach to treat tuberculosis [Internet]. Materials Science and Engineering: C. 2020 ; 112 1-13 art. 110895.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1016/j.msec.2020.110895
Artigo de periodico
Design, synthesis and biological activity of novel substituted 3-benzoic acid derivatives as MtDHFR inhibitors (2020)
Kronenberger, Thales ; Ferreira, Glaucio Monteiro ; Souza, Alfredo Danilo Ferreira de ; Santos, Soraya da Silva; Poso, Antti ; Ribeiro, João Augusto; Tavares, Maurício Temotheo ; Pavan, Fernando Rogério ; Trossini, Gustavo Henrique Goulart ; Dias, Marcio Vinicius Bertacine ; Parise Filho, Roberto
Source: Bioorganic & Medicinal Chemistry. Unidades: FCF, ICB
Subjects: MICROBIOLOGIA, METABÓLITOS, ÁCIDOS CARBOXÍLICOS, DNA, TUBERCULOSE, CINÉTICA QUÍMICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
KRONENBERGER, Thales et al. Design, synthesis and biological activity of novel substituted 3-benzoic acid derivatives as MtDHFR inhibitors. Bioorganic & Medicinal Chemistry, v. 28, n. 15, p. 10 , 2020Tradução . . Disponível em: https://doi.org/10.1016/j.bmc.2020.115600. Acesso em: 14 nov. 2024.
APA
Kronenberger, T., Ferreira, G. M., Souza, A. D. F. de, Santos, S. da S., Poso, A., Ribeiro, J. A., et al. (2020). Design, synthesis and biological activity of novel substituted 3-benzoic acid derivatives as MtDHFR inhibitors. Bioorganic & Medicinal Chemistry, 28( 15), 10 . doi:10.1016/j.bmc.2020.115600
NLM
Kronenberger T, Ferreira GM, Souza ADF de, Santos S da S, Poso A, Ribeiro JA, Tavares MT, Pavan FR, Trossini GHG, Dias MVB, Parise Filho R. Design, synthesis and biological activity of novel substituted 3-benzoic acid derivatives as MtDHFR inhibitors [Internet]. Bioorganic & Medicinal Chemistry. 2020 ; 28( 15): 10 .[citado 2024 nov. 14 ] Available from: https://doi.org/10.1016/j.bmc.2020.115600
Vancouver
Kronenberger T, Ferreira GM, Souza ADF de, Santos S da S, Poso A, Ribeiro JA, Tavares MT, Pavan FR, Trossini GHG, Dias MVB, Parise Filho R. Design, synthesis and biological activity of novel substituted 3-benzoic acid derivatives as MtDHFR inhibitors [Internet]. Bioorganic & Medicinal Chemistry. 2020 ; 28( 15): 10 .[citado 2024 nov. 14 ] Available from: https://doi.org/10.1016/j.bmc.2020.115600
Trabalho de evento-resumo
Dendrímero de poliamidoamina (pamam) de primeira geração: planejamento e síntese de pró-fármaco potencialmente ativo em tuberculose (2019)
Araujo, Renan Vinicius de; Giarolla, Jeanine
Source: Resumos. Conference titles: Simpósio Internacional de Iniciação Científica e Tecnológica da Universidade de São Paulo/SIICUSP. Unidade: FCF
Subjects: PLANEJAMENTO DE FÁRMACOS, TUBERCULOSE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ARAUJO, Renan Vinicius de e GIAROLLA, Jeanine. Dendrímero de poliamidoamina (pamam) de primeira geração: planejamento e síntese de pró-fármaco potencialmente ativo em tuberculose. 2019, Anais.. São Paulo: Pró-Reitoria de Pesquisa/USP, 2019. Disponível em: https://uspdigital.usp.br/siicusp/siicPublicacao.jsp?codmnu=7210. Acesso em: 14 nov. 2024.
APA
Araujo, R. V. de, & Giarolla, J. (2019). Dendrímero de poliamidoamina (pamam) de primeira geração: planejamento e síntese de pró-fármaco potencialmente ativo em tuberculose. In Resumos. São Paulo: Pró-Reitoria de Pesquisa/USP. Recuperado de https://uspdigital.usp.br/siicusp/siicPublicacao.jsp?codmnu=7210
NLM
Araujo RV de, Giarolla J. Dendrímero de poliamidoamina (pamam) de primeira geração: planejamento e síntese de pró-fármaco potencialmente ativo em tuberculose [Internet]. Resumos. 2019 ;[citado 2024 nov. 14 ] Available from: https://uspdigital.usp.br/siicusp/siicPublicacao.jsp?codmnu=7210
Vancouver
Araujo RV de, Giarolla J. Dendrímero de poliamidoamina (pamam) de primeira geração: planejamento e síntese de pró-fármaco potencialmente ativo em tuberculose [Internet]. Resumos. 2019 ;[citado 2024 nov. 14 ] Available from: https://uspdigital.usp.br/siicusp/siicPublicacao.jsp?codmnu=7210
Trabalho de evento-resumo periodico
Determination of co-encapsulation efficiency of tuberculostatic drugs in PLGA nanospheres by capillary electrophoresis (2018)
Yataco Lazaro, Lourdes Marcela; Prado, Fernando Kaneko; Santamaria, Jesus; Fernandez, Javier; Arruebo, Manuel; Sebastian, Victor; Tavares, Marina Franco Maggi ; Aurora-Prado, Maria Segunda
Source: Brazilian Journal of Pharmaceutical Sciences. Conference titles: Pharmaceutical Science and Technology Meeting of the Faculty of Pharmaceutical Sciences, University of São Paulo. Unidades: IQ, FCF
Subjects: TUBERCULOSE, FÁRMACOS, TÉCNICAS DE DIAGNÓSTICO E PROCEDIMENTOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
YATACO LAZARO, Lourdes Marcela et al. Determination of co-encapsulation efficiency of tuberculostatic drugs in PLGA nanospheres by capillary electrophoresis. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Instituto de Química, Universidade de São Paulo. . Acesso em: 14 nov. 2024. , 2018
APA
Yataco Lazaro, L. M., Prado, F. K., Santamaria, J., Fernandez, J., Arruebo, M., Sebastian, V., et al. (2018). Determination of co-encapsulation efficiency of tuberculostatic drugs in PLGA nanospheres by capillary electrophoresis. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Instituto de Química, Universidade de São Paulo.
NLM
Yataco Lazaro LM, Prado FK, Santamaria J, Fernandez J, Arruebo M, Sebastian V, Tavares MFM, Aurora-Prado MS. Determination of co-encapsulation efficiency of tuberculostatic drugs in PLGA nanospheres by capillary electrophoresis. Brazilian Journal of Pharmaceutical Sciences. 2018 ; 54 17 res. FCF030.[citado 2024 nov. 14 ]
Vancouver
Yataco Lazaro LM, Prado FK, Santamaria J, Fernandez J, Arruebo M, Sebastian V, Tavares MFM, Aurora-Prado MS. Determination of co-encapsulation efficiency of tuberculostatic drugs in PLGA nanospheres by capillary electrophoresis. Brazilian Journal of Pharmaceutical Sciences. 2018 ; 54 17 res. FCF030.[citado 2024 nov. 14 ]
Trabalho de evento-resumo periodico
Innovative approach for the treatment of ocular tuberculosis: rifampicin cationic nanoemulsion (2018)
Henostroza, Mirla Anali Bazan; Bou-Chacra, Nadia Araci
Source: Brazilian Journal of Pharmaceutical Sciences. Conference titles: Pharmaceutical Science and Technology Meeting of the Faculty of Pharmaceutical Sciences, University of São Paulo. Unidade: FCF
Subjects: TUBERCULOSE, MYCOBACTERIUM TUBERCULOSIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HENOSTROZA, Mirla Anali Bazan e BOU-CHACRA, Nadia Araci. Innovative approach for the treatment of ocular tuberculosis: rifampicin cationic nanoemulsion. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 14 nov. 2024. , 2018
APA
Henostroza, M. A. B., & Bou-Chacra, N. A. (2018). Innovative approach for the treatment of ocular tuberculosis: rifampicin cationic nanoemulsion. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
NLM
Henostroza MAB, Bou-Chacra NA. Innovative approach for the treatment of ocular tuberculosis: rifampicin cationic nanoemulsion. Brazilian Journal of Pharmaceutical Sciences. 2018 ; 54 70 res. FCF135.[citado 2024 nov. 14 ]
Vancouver
Henostroza MAB, Bou-Chacra NA. Innovative approach for the treatment of ocular tuberculosis: rifampicin cationic nanoemulsion. Brazilian Journal of Pharmaceutical Sciences. 2018 ; 54 70 res. FCF135.[citado 2024 nov. 14 ]
Trabalho de evento-resumo periodico
Molecular modeling studies of PAMAM dendrimer prodrug potentially active in tuberculosis (2018)
Araujo, Renan Vinicius de; Savino, Débora Feliciano; Giarolla, Jeanine
Source: Brazilian Journal of Pharmaceutical Sciences. Conference titles: Pharmaceutical Science and Technology Meeting of the Faculty of Pharmaceutical Sciences, University of São Paulo. Unidade: FCF
Subjects: MODELAGEM MOLECULAR, TUBERCULOSE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ARAUJO, Renan Vinicius de e SAVINO, Débora Feliciano e GIAROLLA, Jeanine. Molecular modeling studies of PAMAM dendrimer prodrug potentially active in tuberculosis. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 14 nov. 2024. , 2018
APA
Araujo, R. V. de, Savino, D. F., & Giarolla, J. (2018). Molecular modeling studies of PAMAM dendrimer prodrug potentially active in tuberculosis. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
NLM
Araujo RV de, Savino DF, Giarolla J. Molecular modeling studies of PAMAM dendrimer prodrug potentially active in tuberculosis. Brazilian Journal of Pharmaceutical Sciences. 2018 ; 54 68 res. FCF132.[citado 2024 nov. 14 ]
Vancouver
Araujo RV de, Savino DF, Giarolla J. Molecular modeling studies of PAMAM dendrimer prodrug potentially active in tuberculosis. Brazilian Journal of Pharmaceutical Sciences. 2018 ; 54 68 res. FCF132.[citado 2024 nov. 14 ]
Trabalho de evento-resumo periodico
Synthesis of dendrimer prodrugs potentially active in malaria and tuberculosis (2018)
Prieto, Diego Campos; Grayson, Scott; Giarolla, Jeanine
Source: Brazilian Journal of Pharmaceutical Sciences. Conference titles: Pharmaceutical Science and Technology Meeting of the Faculty of Pharmaceutical Sciences, University of São Paulo. Unidade: FCF
Subjects: TUBERCULOSE, MALÁRIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PRIETO, Diego Campos e GRAYSON, Scott e GIAROLLA, Jeanine. Synthesis of dendrimer prodrugs potentially active in malaria and tuberculosis. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 14 nov. 2024. , 2018
APA
Prieto, D. C., Grayson, S., & Giarolla, J. (2018). Synthesis of dendrimer prodrugs potentially active in malaria and tuberculosis. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
NLM
Prieto DC, Grayson S, Giarolla J. Synthesis of dendrimer prodrugs potentially active in malaria and tuberculosis. Brazilian Journal of Pharmaceutical Sciences. 2018 ; 54 38 res. FCF072.[citado 2024 nov. 14 ]
Vancouver
Prieto DC, Grayson S, Giarolla J. Synthesis of dendrimer prodrugs potentially active in malaria and tuberculosis. Brazilian Journal of Pharmaceutical Sciences. 2018 ; 54 38 res. FCF072.[citado 2024 nov. 14 ]
Trabalho de evento-resumo periodico
Innovative approach to treatment of ocular tuberculosis: cationic Nanoemulsion (2017)
Henostroza, Mirla Anali Bazan; Araujo, Gabriel Lima Barros de ; Bou-Chacra, Nadia Araci
Source: Brazilian Journal of Pharmaceutical Sciences. Conference titles: Pharmaceutical Science and Technology Meeting of the Faculty of Pharmaceutical Sciences, University of São Paulo. Unidade: FCF
Subjects: TUBERCULOSE, BIODISPONIBILIDADE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HENOSTROZA, Mirla Anali Bazan e ARAUJO, Gabriel Lima Barros de e BOU-CHACRA, Nadia Araci. Innovative approach to treatment of ocular tuberculosis: cationic Nanoemulsion. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 14 nov. 2024. , 2017
APA
Henostroza, M. A. B., Araujo, G. L. B. de, & Bou-Chacra, N. A. (2017). Innovative approach to treatment of ocular tuberculosis: cationic Nanoemulsion. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
NLM
Henostroza MAB, Araujo GLB de, Bou-Chacra NA. Innovative approach to treatment of ocular tuberculosis: cationic Nanoemulsion. Brazilian Journal of Pharmaceutical Sciences. 2017 ; 53 16 res. FCF027.[citado 2024 nov. 14 ]
Vancouver
Henostroza MAB, Araujo GLB de, Bou-Chacra NA. Innovative approach to treatment of ocular tuberculosis: cationic Nanoemulsion. Brazilian Journal of Pharmaceutical Sciences. 2017 ; 53 16 res. FCF027.[citado 2024 nov. 14 ]
Trabalho de evento-resumo periodico
Phosphopantetheine adenylyltransferase potential inhibitors for the treatment of tuberculosis: design, synthesis and biological activity evaluation (2017)
Primi, Marina Candido; Klein, Larry; Sant’Anna, Carlos Mauricio Rabello de; Franzblau, Scott Gary; Ferreira, Elizabeth Igne
Source: Brazilian Journal of Pharmaceutical Sciences. Conference titles: Pharmaceutical Science and Technology Meeting of the Faculty of Pharmaceutical Sciences, University of São Paulo. Unidade: FCF
Subjects: RESISTÊNCIA MICROBIANA ÀS DROGAS, TUBERCULOSE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PRIMI, Marina Candido et al. Phosphopantetheine adenylyltransferase potential inhibitors for the treatment of tuberculosis: design, synthesis and biological activity evaluation. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 14 nov. 2024. , 2017
APA
Primi, M. C., Klein, L., Sant’Anna, C. M. R. de, Franzblau, S. G., & Ferreira, E. I. (2017). Phosphopantetheine adenylyltransferase potential inhibitors for the treatment of tuberculosis: design, synthesis and biological activity evaluation. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
NLM
Primi MC, Klein L, Sant’Anna CMR de, Franzblau SG, Ferreira EI. Phosphopantetheine adenylyltransferase potential inhibitors for the treatment of tuberculosis: design, synthesis and biological activity evaluation. Brazilian Journal of Pharmaceutical Sciences. 2017 ; 53 26 res. FCF047.[citado 2024 nov. 14 ]
Vancouver
Primi MC, Klein L, Sant’Anna CMR de, Franzblau SG, Ferreira EI. Phosphopantetheine adenylyltransferase potential inhibitors for the treatment of tuberculosis: design, synthesis and biological activity evaluation. Brazilian Journal of Pharmaceutical Sciences. 2017 ; 53 26 res. FCF047.[citado 2024 nov. 14 ]
Trabalho de evento-resumo periodico
Rifampicin nanocrystal: towards improved antituberculosis therapy (2016)
Melo, Katherine Jasmine Curo; Ferraz, Humberto Gomes ; Bou-Chacra, Nadia Araci
Source: Brazilian Journal of Pharmaceutical Sciences. Conference titles: Pharmaceutical Sciences and Technology Meeting of the Faculty of Pharmaceutical Sciences, University of São Paulo. Unidade: FCF
Assunto: TUBERCULOSE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MELO, Katherine Jasmine Curo e FERRAZ, Humberto Gomes e BOU-CHACRA, Nadia Araci. Rifampicin nanocrystal: towards improved antituberculosis therapy. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 14 nov. 2024. , 2016
APA
Melo, K. J. C., Ferraz, H. G., & Bou-Chacra, N. A. (2016). Rifampicin nanocrystal: towards improved antituberculosis therapy. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
NLM
Melo KJC, Ferraz HG, Bou-Chacra NA. Rifampicin nanocrystal: towards improved antituberculosis therapy. Brazilian Journal of Pharmaceutical Sciences. 2016 ; 52 44 res. FCF083.[citado 2024 nov. 14 ]
Vancouver
Melo KJC, Ferraz HG, Bou-Chacra NA. Rifampicin nanocrystal: towards improved antituberculosis therapy. Brazilian Journal of Pharmaceutical Sciences. 2016 ; 52 44 res. FCF083.[citado 2024 nov. 14 ]
Trabalho de evento-resumo periodico
Rifampicin cationic nanoemulsion for the treatment of ocular tuberculosis (2016)
Henostroza, Mirla Anali Bazan; Bou-Chacra, Nadia Araci
Source: Brazilian Journal of Pharmaceutical Sciences. Conference titles: Pharmaceutical Sciences and Technology Meeting of the Faculty of Pharmaceutical Sciences, University of São Paulo. Unidade: FCF
Subjects: TUBERCULOSE, NANOTECNOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HENOSTROZA, Mirla Anali Bazan e BOU-CHACRA, Nadia Araci. Rifampicin cationic nanoemulsion for the treatment of ocular tuberculosis. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 14 nov. 2024. , 2016
APA
Henostroza, M. A. B., & Bou-Chacra, N. A. (2016). Rifampicin cationic nanoemulsion for the treatment of ocular tuberculosis. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
NLM
Henostroza MAB, Bou-Chacra NA. Rifampicin cationic nanoemulsion for the treatment of ocular tuberculosis. Brazilian Journal of Pharmaceutical Sciences. 2016 ; 52 40 res. FCF075.[citado 2024 nov. 14 ]
Vancouver
Henostroza MAB, Bou-Chacra NA. Rifampicin cationic nanoemulsion for the treatment of ocular tuberculosis. Brazilian Journal of Pharmaceutical Sciences. 2016 ; 52 40 res. FCF075.[citado 2024 nov. 14 ]

USP Schools

ReP

Filtros

Departament

Authors

USP affiliated authors

Date published

Subjects

Source title

Publisher

Conference titles

Countries/Territories

Grupo de pesquisa

Funding Agencies

Indexado em

Normalized affiliation

Non normalized affiliation

Countries of institutions of collaboration